Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
glioblastoma
MedTech
Novocure device fails to improve brain cancer patients’ survival
Novocure’s tumor-treating electric fields device missed its primary endpoint in a late-stage glioblastoma trial.
Ben Adams
Jun 18, 2026 8:25am
CNS Pharma wipes glioblastoma pipeline clean in strategic pivot
Mar 11, 2026 10:30am
Potential brain tumor pill shrinks tumors in mice
Jan 28, 2026 2:00pm
Cash-strapped TME rethinks eye drug plan after losing partner
Jan 5, 2026 6:50am
Imvax takes brain cancer therapy to FDA despite missing primary
Dec 2, 2025 8:00am
BioLineRx forges joint cancer venture with Norwegian biotech
Sep 29, 2025 11:22am
